Enliven Inc.
4Patents
3Active
4Granted
55Portfolio score
Filing activity: Sep 2, 1998 → Aug 11, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6393407B1 | Tracking user micro-interactions with web page advertising | Physics | 178 | Expired |
| US11807638B2 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | Chemistry; Metallurgy | 1 | Active |
| US11767321B2 | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases | Chemistry; Metallurgy | 1 | Active |
| US12240846B2 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.